RNS
ALXN

Robert N. Shapiro’s Alexion Pharmaceuticals ALXN Stock Holding History

Robert N. Shapiro’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$12K Buy
65
+35
+117% +$6.49K ﹤0.01% 676
2014
Q3 		$5K Buy
+30
New +$4.93K ﹤0.01% 754

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Robert N. Shapiro's ALXN Position: Q4 2014 in Review

Robert N. Shapiro increased its Alexion Pharmaceuticals (ALXN) stake by 117% in Q4 2014, buying an estimated $6.49K and bringing the position to 65 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #676.

Robert N. Shapiro first reported a position in ALXN in Q3 2014 and has held it in 2 quarters since. 578 funds tracked by Wall St. Rank hold ALXN as of Q4 2014.

  • Robert N. Shapiro held 65 shares of Alexion Pharmaceuticals worth $12K as of Q4 2014.
  • Robert N. Shapiro bought 35 Alexion Pharmaceuticals shares in Q4 2014, an estimated $6.49K.
  • Alexion Pharmaceuticals made up ﹤0.01% of Robert N. Shapiro's portfolio in Q4 2014, its #676 holding.
  • Robert N. Shapiro first reported a position in Alexion Pharmaceuticals in Q3 2014 and has held it in 2 quarters since.
  • 578 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.